insights_auto
Why is TNDM down २.५७%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
US$ १६.१०
arrow_downward
-२.५७%(-०.४३) 1D
अक्टोबर ६, १५:५०:२४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
US$ १६.७७
High
US$ १७.०५
Low
US$ १५.९४
Mkt. cap
१.१२ अरब
Avg. vol.
१९.३२ लाख
Volume
९.०४ लाख
52-wk high
US$ २९.६५
52-wk low
US$ १२.२६
EPS
-US$ ०.९३
Beta
१.६६
Shares outstanding
६.९६ करोड
No. of employees
२ हजार
Open
US$ १६.७७
High
US$ १७.०५
Low
US$ १५.९४
Mkt. cap
१.१२ अरब
Avg. vol.
१९.३२ लाख
Volume
९.०४ लाख
52-wk high
US$ २९.६५
52-wk low
US$ १२.२६
EPS
-US$ ०.९३
Beta
१.६६
Shares outstanding
६.९६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
१ दिन पहिले
Tandem Diabetes Care stock gains 2.36 percent before Q3 results
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc